Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators, particularly targeting 5-HT2A and 5-HT2C receptors. Shows potential in the development of treatments for neurological and psychiatric disorders such as depression, anxiety, and schizophrenia. Its structural features allow for high selectivity and binding affinity in central nervous system targets. Also employed in structure-activity relationship (SAR) studies to optimize azepine-based drug candidates for improved metabolic stability and bioavailability.